Print Page

給 業 界 的 信
 
FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes (Letter to Healthcare Professionals) (English Only)
 
 
 
附件:
  1. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes  
Related Information:
Australia: Update: fluoroquinolone antibiotics and adverse events (English only) 上載於 2020-02-27
美國：食物及藥物管理局加強氟喹諾酮抗生素嚴重低血糖和精神健康副作用的安全信息；需要更改標籤 上載於 2018-07-11
 
back